"We are doing a lot of research in the area of bio-informatics, which is coming up in a big way. Our major focus is on cancer treatment using supercomputers as tool. We have interacted with Tata Memorial Hospital in Mumbai and the National Cancer Institute in the US for doing simulation with the 'P53' molecule on our system", Director General C-DAC, Dr. Hemant Darbari stated.
'P53', also known as TP53 or tumour protein is a gene that codes for a protein that regulates the cell cycle and hence functions as tumour suppressor.
Speaking at the unveiling of C-DAC's new supercomputer, the PARAM Shavak-Virtual Reality (VR), Dr. Hermant Darbari said that his team is also working on 'Drug repurposing'.
Drug repositioning - also known as drug repurposing - is the application of known drugs and compounds to treat new diseases.
Under this concept, C-DAC is working on repurposing, in which drugs used for diabetes can be used for breast cancer research.
These are some of the major initiatives that will be backed up with artificial intelligence.
The new supercomputer will help its users to extend the reach beyond traditional domains of design manufacturing and entertainment.
The diabetes drug used on human beings is promising and work is ongoing to redirect it towards breast cancer treatment. The team is also trying to use some ancient knowledge from Ayurveda and check its impact on cancer treatment.
"PARAM Shavak provides the computing power necessary to keep academic institutions on the leading edge in today's competitive market at affordable cost", stated Dr. Hermant Darbari.
"This system is meant for research organisations and academic institutions that are on the verge of adopting high performance computing (HPC) culture in their institutions", DG C-DAC Dr. Hermant Darbari stated.